1. Home
  2. MBIO vs ELWS Comparison

MBIO vs ELWS Comparison

Compare MBIO & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • ELWS
  • Stock Information
  • Founded
  • MBIO 2015
  • ELWS 2018
  • Country
  • MBIO United States
  • ELWS Japan
  • Employees
  • MBIO N/A
  • ELWS N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • ELWS
  • Sector
  • MBIO Health Care
  • ELWS
  • Exchange
  • MBIO Nasdaq
  • ELWS Nasdaq
  • Market Cap
  • MBIO 7.3M
  • ELWS 6.0M
  • IPO Year
  • MBIO N/A
  • ELWS 2023
  • Fundamental
  • Price
  • MBIO $1.17
  • ELWS $1.85
  • Analyst Decision
  • MBIO Strong Buy
  • ELWS
  • Analyst Count
  • MBIO 1
  • ELWS 0
  • Target Price
  • MBIO $100.00
  • ELWS N/A
  • AVG Volume (30 Days)
  • MBIO 1.1M
  • ELWS 24.4K
  • Earning Date
  • MBIO 05-20-2025
  • ELWS 06-03-2025
  • Dividend Yield
  • MBIO N/A
  • ELWS N/A
  • EPS Growth
  • MBIO N/A
  • ELWS N/A
  • EPS
  • MBIO N/A
  • ELWS N/A
  • Revenue
  • MBIO N/A
  • ELWS $2,292,406.00
  • Revenue This Year
  • MBIO N/A
  • ELWS N/A
  • Revenue Next Year
  • MBIO N/A
  • ELWS N/A
  • P/E Ratio
  • MBIO N/A
  • ELWS N/A
  • Revenue Growth
  • MBIO N/A
  • ELWS 404.13
  • 52 Week Low
  • MBIO $1.01
  • ELWS $1.04
  • 52 Week High
  • MBIO $65.00
  • ELWS $8.68
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 39.20
  • ELWS 41.85
  • Support Level
  • MBIO $1.01
  • ELWS $1.81
  • Resistance Level
  • MBIO $1.22
  • ELWS $1.96
  • Average True Range (ATR)
  • MBIO 0.09
  • ELWS 0.17
  • MACD
  • MBIO 0.03
  • ELWS -0.00
  • Stochastic Oscillator
  • MBIO 41.89
  • ELWS 11.50

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About ELWS Earlyworks Co. Ltd.

Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.

Share on Social Networks: